Mylan news from FiercePharma
News
Mylan to cut 100 in Puerto Rico
Workers in Caguas, Puerto Rico, braced for the axe as Mylan announced it would eliminate 100 of the 500 positions at that manufacturing plant. The generics maker announced back in March that it would Read more...
Mylan to sell copycat of Teva MS drug
Here's a turnabout-is-fair-play story. Generics maker Teva Pharmaceuticals, known for its aggressive challenges to brand-name drugs, is getting challenged itself. The company has one very big branded Read more...
Mylan's Robert Coury - CEO Pay
Robert Coury - Mylan Total Compensation: $8.54M 2007 Revenue: $2.17B2006 Revenue: $1.61BChange: 34% Details: Mylan CEO and Vice Chairman Robert Coury brought down $10.3 million during Read more...
Actavis hit with suit over recalled Digitek
Maybe not faster than a speeding bullet, but close. Lawyers already are filing a class-action lawsuit against Iceland's Actavis over the recalled heart drug Digitek, which was just pulled off the Read more...
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets